Skip to content

Effectiveness evaluation of superselective renal artery embolization in the treatment of renal injury hemorrhage

Effectiveness evaluation of superselective renal artery embolization in the treatment of renal injury hemorrhage

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400085050
Enrollment
Unknown
Registered
2024-05-30
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal injury hemorrhage

Interventions

renal injury hemorrhages group:None

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Age 20-80, any gender; ? Continuous gross hematuria, decreased hemoglobin, dull pain in the affected side of the waist, and confirmed diagnosis of renal hemorrhage through B-ultrasound, CT, MRI, or renal arteriography; ? Closed trauma; ? Continuous bleeding with failure of conservative treatment; ? Willingness to undergo interventional surgical treatment.

Exclusion criteria

Exclusion criteria: ? Patients with bleeding caused by pathological factors such as renal tumors; ? Patients with critical conditions such as difficult hemostasis and severe renal pedicle injury, requiring nephrectomy to save lives; ? Patients with severe dysfunction of heart, liver, kidney, or brain function, unable to undergo interventional surgical treatment; ? Patients with inflammatory and infectious diseases; ? Patients allergic to contrast agents; ? Patients unable to complete follow-up.

Design outcomes

Primary

MeasureTime frame
Hemoglobin;Imaging findings;

Secondary

MeasureTime frame
Urine routine red blood cell count;Drainage tube drainage fluid;

Countries

China

Contacts

Public ContactXiao An

Shanghai General Hospital

drxiaoan@126.com+86 138 1628 7103

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026